Hemophilia Toolkit

Employer Resources

Use these relevant and up-to-date resources to tackle the issues and challenges employers face when creating a strategy for managing bleeding disorders in a covered population.

Organizations

Other Resources

Panelists Discuss Community-Based Approaches to Mitigate Costs, Improve SDOH Outcomes American Journal of Managed Care (AJMC), October 28, 2020
High-Cost Claims and Injectable Drug Trends
Sun Life Financial Stop Loss Research Reports
2022 Report
2024 Report
Institute for Clinical and Economic Review final reports on Hemophilia A
Hemophilia A with inhibitors October 2020
Hemophilia A without inhibitors November 2020
Health care costs and resource use of managing hemophilia A: A targeted literature review
Contemporary approaches to treat people with hemophilia: what’s new and what’s not?
The value‐based healthcare approach to haemophilia: Development of outcome measures for the evaluation of care of people with haemophilia
Haemo-Adhaesione: A New Measure of Adherence for Adolescent and Adult Patients with Haemophilia – DOAJ
Economic burden of haemophilia from a societal perspective: A scoping review. PharmacoEconomics – Open. LINK
Factor IX inhibitors in haemophilia B: A report of the National Haemophilia Registry in China. Haemophilia. LINK
Articles about Hemophilia | Hemophilia | CDC

< Back Back to Toolkit Home Page >

Employer Resources

Hemophilia Toolkit

Employer Resources

Organizations

Other Resources

About Us

Membership

Events

Resources

Members Only